▶ with hydrochlorothiazide, 176
Iron content of different iron salts
Irrigating solutions, bladder, 790
Isolated systolic hypertension, 142
Isometheptene with paracetamol, see
Paracetamol with isometheptene
▶ with ethambutol with pyrazinamide
and rifampicin, see Rifampicin with
▶ with pyrazinamide and rifampicin,
see Rifampicin with isoniazid and
▶ with rifampicin, see Rifampicin with
Isophane Insulin Injection, see
Isophane Insulin (NPH)—intermediate
Isophane Protamine Insulin Injection,
Isopropyl alcohol with chlorhexidine
gluconate with isopropyl alcohol
▶ with mebeverine, see Mebeverine
▶ with lumacaftor, see Lumacaftor
▶ with tezacaftor, see Tezacaftor with
Japanese encephalitis vaccine, 1302,
Jevity preparations, 1558, 1560, 1561
Joint Formulary Committee, vii
Joint prostheses and dental treatment,
antibacterial prophylaxis, 509
Juvenile idiopathic arthritis, 1094
BNF 78 Inosine complexes – Kalcipos-D 1647
Kendall Products, 1595, 1599–1601
Labelling of prescribed medicines, 4
▶ with salicylic acid, see Salicylic acid
▶ with abacavir, see Abacavir with
▶ with abacavir and dolutegravir, see
Abacavir with dolutegravir and
▶ with abacavir and zidovudine, see
▶ with tenofovir disoproxil and
▶ with zidovudine, see Zidovudine
Lanoxin preparations, 109, 110
Latin abbreviations, inside back pages
Ledipasvir with sofosbuvir, 628
Lercanidipine hydrochloride, 161
Leukomed preparations, 1593, 1595, 1596
Leukotriene receptor antagonists, 269
Levemir preparations, 717, 718
Levobunolol hydrochloride, 1180
Levocetirizine hydrochloride, 281
▶ with benserazide, see Co-beneldopa
▶ with carbidopa and entacapone, 417
▶ with carbidopa, see Co-careldopa
▶ with estradiol, see Estradiol with
Ethinylestradiol with levonorgestrel
Lidocaine and Fluorescein, 1177
▶ with fluorescein, see Fluorescein
▶ with methylprednisolone, see
Methylprednisolone with lidocaine
tropicamide, see Tropicamide with
Life support algorithm (image), inside
Lifestyle Products, 1576, 1577
1648 Kaletra – Lifestyle Products BNF 78
Lignocaine hydrochloride, see Lidocaine
Lioresal preparations, 1128, 1129
Lipid modifying drugs, other, 206
▶ with retinol palmitate with white
soft paraffin with light liquid
paraffin and wool, see Retinol
palmitate with white soft paraffin
and light liquid paraffin and liquid
▶ with white soft paraffin and wool
▶ with insulin degludec, see Insulin
Lisdexamfetamine mesilate, 351
▶ with hydrochlorothiazide, 171
Liver disease in dental practice, 36
Liver disorders and related conditions,
▶ with insulin glargine, see Insulin
Local anaesthesia toxicity, 1348
Local corticosteroid injections, 1153
Local inflammation of joints and soft
Lophlex preparations, 1584, 1586
▶ with hydrochlorothiazide, 177
Low back pain and sciatica, 1130
Low molecular weight heparins, 120
Lower urinary-tract infections, 589
L-Tri-iodothyronine sodium, see
Lugol’s Solution, see Iodide with iodine
Lumacaftor with ivacaftor, 294
Lumefantrine with artemether, see
▶ with follitropin alfa, see Follitropin
▶ with anhydrous sodium sulfate,
ascorbic acid, potassium chloride,
▶ with anhydrous sodium sulfate,
bicarbonate and sodium chloride, 52
▶ with potassium chloride, sodium
bicarbonate and sodium chloride, 57
Macrolides, 514, 536, 1171, 1268
▶ with calcium acetate, see Calcium
acetate with magnesium carbonate
▶ with citric acid, see Citric acid with
▶ with magnesium trisilicate and
sodium bicarbonate, see Magnesium
carbonate and sodium bicarbonate
Magnesium glycerophosphate, 1050
▶ with aluminium hydroxide and
simeticone, see Simeticone with
▶ with aluminium hydroxide, see Comagaldrox
Magnesium oxide with aluminium
hydrochloride and simeticone, see
Dicycloverine hydrochloride with
aluminium hydroxide, magnesium
▶ with glycerol and phenol, see
Glycerol with magnesium sulfate
▶ with magnesium carbonate and
MagnEss preparations, 1050, 1051
Malaria prophylaxis, recommended
BNF 78 Lignocaine hydrochloride – Malaria prophylaxis, recommended regimens table 1649
Male sex hormone antagonism, 770
Malignant hyperthermia, 1329, 1346
Mantoux test, see Tuberculin purified
Maple syrup urine disease, 1582
Marketing authorisation and BNF
Mast-cell stabilisers, 270, 1161, 1208
Mastitis during breast-feeding, 517
Maxamum preparations, 1582, 1583,
Measles and normal immunoglobulin,
Measles, Mumps and Rubella vaccine,
Measles, mumps and rubella vaccine,
No comments:
Post a Comment
اكتب تعليق حول الموضوع